Dapagliflozin and metformin """''""

Dapagliflozin and metformin 
PAFAGOLD M  are commonly prescribed together as a combination medication for the management of type 2 diabetes. This combination helps to address different aspects of blood sugar control and can be more effective in certain cases than either medication alone.
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. It works by reducing the reabsorption of glucose by the kidneys, leading to increased excretion of glucose in the urine. This helps lower blood sugar levels.
Metformin is a widely used oral antidiabetic medication. It primarily works by decreasing the production of glucose in the liver, reducing intestinal glucose absorption, and improving insulin sensitivity in peripheral tissues.
When combined, PAFAGOLD M  offer complementary mechanisms of action:
Dapagliflozin helps lower blood sugar levels by removing excess glucose from the body through urine.
Metformin reduces the production of glucose by the liver and improves insulin sensitivity.
The combination of PAFAGOLD M  is often prescribed when blood sugar levels are not adequately controlled with metformin alone or when an individual's diabetes requires multiple medications to manage effectively. It can be an effective option for improving glycemic control in people with type 2 diabetes.
For further information please contact:
info@sterispharma.com
Order now - https://www.sterisonline.com/product/pafagold-m-500-134322